Home › Scleroderma › NCT07228429
Quantification of Calcinosis Cutis Disease Burden Using Computed Tomography Images
Quantification of Calcinosis Cutis Disease Burden in Patients With Systemic Sclerosis Using Computed Tomography Images
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Scleroderma/systemic sclerosis patient with diagnosed calcinosis cutis who will be clinically treated with STS as they would in clinical SOC care * Must be ≥ 18 years old and meet the 2013 American College of Rheumatology criteria for the diagnosis of systemic sclerosis (diffuse or limited) * Receiving clinical care at Yale clinics Exclusion Criteria: * Unable to provide informed consent * Currently pregnant or nursing * Patients with a calcinosis ROI \>6cm
About the study
The main purpose of this study is to develop sensitive radiographic measurement techniques that can be used as outcome measures along with patient-reported outcome instruments in clinical trials of calcinosis cutis treatments, and potentially be used to assess disease course and treatment response in clinical practice. The goal is to test the performance of the software.
What is being tested
- Sodium Thiosulfate (STS) (drug)
- Sodium Thiosulfate Injection (drug)
Sponsor: Yale University · Participants: 56 · Started: Oct 14, 2025
Contact the study team
- Crystal Cheung · Phone: 203-737-5571
Official record on ClinicalTrials.gov — NCT07228429
Locations in the U.S.
| Connecticut | Yale Scleroderma Program, New Haven |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.